The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (10) , 2167-2174
- https://doi.org/10.1046/j.1538-7836.2003.00396.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- CorrespondenceThe Journal of Bone and Joint Surgery. British volume, 1999
- Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgeryBlood Coagulation & Fibrinolysis, 1998
- Natural History of Thromboembolic Disease After Total Hip ArthroplastyPublished by Wolters Kluwer Health ,1996
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgeryPublished by American Medical Association (AMA) ,1987
- NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSISThe Lancet, 1985
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982